Navigation Links
NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
Date:3/7/2009

herpes viruses, yeasts and fungi. In addition, in Phase I human studies, NVC-422 has been shown to be safe and well-tolerated in the nose and bladder. Also, a Phase I trial with NVC-422 for the treatment of eye infections has commenced under the auspices of NovaBay partner Alcon, Inc. (NYSE: ACL).

Preclinical Study Details and Results

The purpose of the current study was to identify the optimal dosage and delivery of NVC-422 for treating Trichophyton mentagrophytes dermatophyte based on an established animal model previously used in the preclinical evaluation of terbinafine (Lamisil(R)) and itraconazole (Sporanox(R)). Guinea pigs were randomized to either placebo or doses of NVC-422 of 0.5%, 1.0%, 1.5%, or 2.0% applied to infected skin three times a day for seven days. Evaluation of clinical and mycological efficacies was performed three days after completion of treatment. Skin biopsies were performed for analysis.

Clinical efficacy rates of NVC-422 ranged from 23.7% for the lowest dose to 36.6% for the highest dose compared to 3.6% for placebo. Mycological efficacy rates ranged from 86.0% for the lowest dose to 97.9% for the highest dose compared to 53.8% for placebo. Furthermore, when compared to a previous clinical study, high dose NVC-422 showed superior clinical and mycological efficacy rates in this animal model compared to ciclopirox (Penlac(R)), a well-established topical antifungal agent (36.6% and 97.9% versus 7.2% and 85.0%, respectively).

About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals is a mid-stage biopharmaceutical company developing first-in-class, novel, synthetic anti-infective product candidates that are bioequivalent to the active antimicrobial molecules generated within white blood cells to treat and prevent a wide range of infections wi
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
2. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
3. Adlyfe Strikes Translational Medicine Partnership With Wyeth Pharmaceuticals for Alzheimers Biomarker Assay
4. MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
5. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
6. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
7. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
8. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
9. Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments
10. Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer
11. Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015  IGI Laboratories, Inc. (NYSE ... based specialty generic pharmaceutical company, announced the Company will ... Tuesday, April 28, 2015 to discuss the 1st quarter ... listen to the call by dialing 1-888-346-3479. International participants ... should ask to be joined into the IGI Laboratories, ...
(Date:4/24/2015)...  Span-America Medical Systems, Inc. (NASDAQ:  SPAN) announced ... second quarter results on Thursday, April 30, after the ... will conduct a conference call at 10:00 a.m. ... financial and operating results for the second quarter ended ... conference call will be available online at ...
(Date:4/24/2015)... -- Introduction of new "Elements" ... for radiosurgery/SBRT   The "Elements" strategy ... the workflow for difficult to treat indications in ... comes full circle with the introduction of automated ... enable on-the-fly generation of consistent treatment plans for ...
Breaking Medicine Technology:Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2
... Pharmaceuticals, Inc. (Nasdaq: DUSA) announces that its ... will be issued on Friday, November 5th at 6:30 ... 8:30 a.m. Friday, November 5th - 8:30 a.m. E.D.T.If ... callers use:502-719-4466Password - DUSAA replay of the call will ...
... BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial -- CARMIEL, Israel, Nov. 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
Cached Medicine Technology:Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 2Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 3Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 4Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 5Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 6Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 7Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 8Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 9Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial 10
(Date:4/26/2015)... 2015 A live auction will be ... from hospitals, surgery centers and other medical facilities around ... sold including radiology, surgery, endoscopy, lab, anesthesia, exam and ... place Tuesday, April 28th starting at 10:00am EDT. The ... 5025 North Hiatus Rd., Sunrise, FL 33351. Anyone ...
(Date:4/26/2015)... 26, 2015 In an article published ... evaluated the head-neck biomechanics occurring during the use of handheld ... able to determine that use of a tablet increases mechanical ... 5 times - more than when the neck is in ... a study, but pointing out the potential hazards of overuse ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 MidSouth ... grow throughout the Southeast. MidSouth Pain Treatment Center is ... in Cordova, Southaven, Oxford and Jackson, two ambulatory surgery ... in the Southaven and Cordova locations. , Dr. ... ”I went into medicine to help people, and when ...
(Date:4/25/2015)... 2015 Avid Collector Andrew Hawley from ... Stones Greensboro Coliseum concert posters. The concert was held ... Stone's Second American Tour. , According to Hawley, ... of Baltimore, Maryland. This poster blank was used to ... cites. Globe uses garish lettering and colors on this ...
(Date:4/25/2015)... In the United States alone, an ... treatment for an illicit drug or alcohol ... Mental Health Services Administration’s Survey on Drug Use and ... are harrowing stories of men and women whose lives ... David H. Kerr , founder and retired president of ...
Breaking Medicine News(10 mins):Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3
... Incorporated debuts Generation Max(TM) as students start back to ... driver Rudd celebrates 900th career start, HACKETTSTOWN, N.J., Sept. ... start at the California Speedway on,Sept. 2nd - a milestone ... this race, Rudd,s #88 Snickers(R) Ford Fusion will be outfitted,with ...
... other racial minorities have sleep durations associated with increased ... unhealthy sleep patterns among minorities long sleep or ... to a study published in the September 1 issue ... Lauren Hale, PhD, assistant professor in the graduate program ...
... Aug. 31 A recent government report shows ... million. The uninsured often,have limited access to preventive ... increasing the chance that avoidable medical,conditions will send ... that,can help people get the medicines prescribed by ...
... TOLEDO, Ohio, Aug. 31 Manor Care, Inc. (NYSE:,HCR) ... October 17,2007 as the date for a special meeting ... Care by an affiliate of global private equity,firm The ... the record,date for the meeting. On August 6, 2007, ...
... disease outbreaks, experts warn , , FRIDAY, Aug. 31 (HealthDay ... been remarkably successful, virtually eliminating diseases like measles and ... be appearing in the public health system that would ... are readily available. , That,s because a sizable segment ...
... (Amex: ZTM ), today announced that Gregory Halpern ... Release he signed on August,20, 2007. Under the ... three months, salary plus unused vacation and would have ... In addition, under,the Agreement the Company would have received ...
Cached Medicine News:Health News:Video: Nutrition Comes to NASCAR 2Health News:Video: Nutrition Comes to NASCAR 3Health News:Minorities more likely to have sleep durations associated with increased mortality 2Health News:Minorities more likely to have sleep durations associated with increased mortality 3Health News:Manor Care, Inc. Announces Record Date for Special Stockholder Meeting 2Health News:Growing Number of U.S. Kids Not Getting Needed Vaccinations 2Health News:Growing Number of U.S. Kids Not Getting Needed Vaccinations 3Health News:Growing Number of U.S. Kids Not Getting Needed Vaccinations 4Health News:Z Trim Announces Revocation of Gregory Halpern Severence Agreement 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: